- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01644760
Respiratory Variations in the Diameter of the Inferior Vena Cava With Spontaneous Ventilation
Respiratory Variations in the Diameter of the Inferior Vena Cava With Spontaneous Ventilation: A Physiological Study on Healthy Volunteers
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Secondary objectives of this study are:
- to determine a threshold value of diaphragmatic excursion (ultrasound measures: expiration versus inspiration)that best predicts a 40% collapsibility of the inferior vena cava (IVC).
- to determine a threshold value of diaphragmatic excursion (ultrasound measures: expiration versus inspiration)that best predicts a 100% collapsibility of the IVC.
- to determine the location of the cutting plane for the TM analysis of collapsibility of the IVC.
- to evaluate the hemodynamic conditions of normal healthy volunteers.
- to detect any abnormality of cardiac function.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nîmes, France, 30029
- CHU de Nîmes - Hopital Universitaire Caremeau
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- The volunteer must have given his/her informed and signed consent
- The volunteer must be insured or beneficiary of a health insurance plan
Exclusion Criteria:
- The volunteer is participating in another study
- The volunteer is in an exclusion period determined by a previous study
- The volunteer is under judicial protection, under tutorship or curatorship
- The volunteer refuses to sign the consent
- It is impossible to correctly inform the volunteer
- The patient is pregnant, parturient, or breastfeeding
- The volunteer has known heart disease like heart failure, cardiac arrhythmia
- The volunteer takes cardiotropics
- The volunteer has known lung disease: obstructive or restrictive respiratory failure
- The volunteer has clinical signs of COPD (coughing with morning sputum in a smoking subject)
- Any emergency situation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Study population
Healthy subjects with spontaneous ventilation, 18 to 50 years of age.
|
The patient will have cardiac, abdominal and thoracic ultrasounds with controlled and monitored inspiratory effort.
This gesture takes about 40 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Collapsibility score for the IVC diameter
Time Frame: Baseline (Day 0; cross-sectional study)
|
percentage = ((max-min)/average)*100% Three variables are necessary to respond to the primary objective: (the collapsibility score for the IVC diameter; (2) whether or not this score is >= 50%; and (3) a measure of the diaphragmatic excursion. |
Baseline (Day 0; cross-sectional study)
|
|
Collapsibility score for the IVC diameter >= 50% (presence/absence)
Time Frame: Baseline (Day 0; cross-sectional study)
|
percentage = ((max-min)/average)*100% Three variables are necessary to respond to the primary objective: (the collapsibility score for the IVC diameter; (2) whether or not this score is >= 50%; and (3) a measure of the diaphragmatic excursion. |
Baseline (Day 0; cross-sectional study)
|
|
Diaphragmatic excursion
Time Frame: Baseline (Day 0; cross-sectional study)
|
Maximum distance between the position of the diaphragmatic dome during inspiration versus expiration (cm) Three variables are necessary to respond to the primary objective: (the collapsibility score for the IVC diameter; (2) whether or not this score is >= 50%; and (3) a measure of the diaphragmatic excursion. |
Baseline (Day 0; cross-sectional study)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Collapsibility score for the IVC diameter >= 40% (presence/absence)
Time Frame: Baseline (Day 0; cross sectional study)
|
percentage = ((max-min)/average)*100%
|
Baseline (Day 0; cross sectional study)
|
|
Collapsibility score for the IVC diameter >= 60% (presence/absence)
Time Frame: Baseline (Day 0; cross sectional study)
|
percentage = ((max-min)/average)*100%
|
Baseline (Day 0; cross sectional study)
|
|
Mitral Doppler Wave E speed
Time Frame: Baseline (Day 0; cross sectional study)
|
cm/s
|
Baseline (Day 0; cross sectional study)
|
|
Mitral Doppler Wave A speed
Time Frame: Baseline (Day 0; cross sectional study)
|
cm/s
|
Baseline (Day 0; cross sectional study)
|
|
Tissue Doppler Wave E' speed
Time Frame: Baseline (Day 0; cross sectional study)
|
cm/s
|
Baseline (Day 0; cross sectional study)
|
|
Simpson: FEVG
Time Frame: Baseline (Day 0; cross sectional study)
|
%
|
Baseline (Day 0; cross sectional study)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Laurent Muller, MD, Centre Hospitalier Universitaire de Nîmes
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LOCAL/2012/LM-01
- 2012-A00625-38 (Other Identifier: ANSM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.